With any oral appliance on the market, studies show that more than 75 percent of people with severe sleep-disordered breathing improve their sleep significantly1. About 54 percent improve to measure an AHI level of less than 10. Of those who do not improve to less than 10, 21 per cent of these will improve their AHI level by at least half1.
More than 1000 people are now using the O2VentTM Mono. The Oventus clinical trial reported an average usage of the device six nights per week and an average of seven hours per night, resulting in a compliance of 82.8%2. This study also showed that 100 percent of patients experienced a significant reduction in snoring and an improvement in AHI with 82 percent of patients eliminating snoring completely and 76 percent of patients reducing their AHI by more than half2.
If you are interested in the O2VentTM, call us to discuss your individual situation.
1. Sutherland, et. al, Oral Appliance Treatment for Obstructive Sleep Apnea: An Update. Journal of Clinical Sleep Medicine. February 15 2014.
2. Lavery D, Hart C et al. Safety and Efficacy of a Novel Oral Appliance in the Treatment of Obstructive Sleep Apnea. Journal of Dental Sleep Medicine Vol.4 No.3 July 2017